Historical record - last NADAC effective date: 3/20/2019
Product Information
AMLODIPINE-VALSARTAN 10-160 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4388 per EA under NDC 43386008209. Its NADAC has been published 191 times since Aug 12, 2015.
FDA first approved this application on Mar 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the amlodipine and valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 160 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386008209
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/20/2019
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202829FDA Approved
3/30/2015
TE Code
AB
On Market Since
3/30/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 10-160 MG has been published 191 times since Aug 12, 2015, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4388 per EA |
|---|---|
| All-time high | $2.1311 (Oct 14, 2015) |
| All-time low | $0.3709 (Nov 21, 2018) |
| Median price | $0.5546 |
| Average price | $0.6096 |
| Largest weekly change | -75.0% (Oct 21, 2015) |
| Weeks tracked | 191 |
| Tracking since | Aug 12, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-79.4%
Last surveyed Apr 3, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 10-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-160 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.4388 per EA (NDC 43386008209), effective Apr 3, 2019.
How has the price of AMLODIPINE-VALSARTAN 10-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has declined 79.4%. It has been tracked across 191 weekly CMS publications since Aug 12, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-160 MG?
Since Aug 12, 2015, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has ranged from a low of $0.3709 (Nov 21, 2018) to a high of $2.1311 (Oct 14, 2015), with a median of $0.5546 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-160 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-VALSARTAN 10-160 MG, is $0.3592 per EA — about 18% below AMLODIPINE-VALSARTAN 10-160 MG.
Who manufactures AMLODIPINE-VALSARTAN 10-160 MG?
AMLODIPINE-VALSARTAN 10-160 MG (NDC 43386008209) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.